CP
Chinese PLA General Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Chinese PLA General Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its sessions centre on new targeted drugs in HER2-positive gastric cancer, neuroendocrine neoplasms and other advanced solid tumours, plus imaging in kidney cancer. Highlights include a bispecific antibody-drug conjugate against EGFR and B7H3, and a CAIX-targeted PET/CT scan for diagnosing and staging clear cell renal cell carcinoma.
| Organization | ESMO 2026 Attendance |
|---|---|
CP Chinese PLA General Hospital Beijing, China | |
Military general hospital of the Chinese People's Liberation Army in Beijing, China, organised into several medical centres. | Abstract Fri Oct 23 16:20–16:25 Abstract Sat Oct 24 15:05–15:15 Abstract Sun Oct 25 14:55–15:00 Abstract Mon Oct 26 10:35–10:45 2393O - First results from a phase 2 trial of second-line pumitamig (PD-L1 × VEGF-A bsAb) plus chemotherapy in unresectable neuroendocrine neoplasms Sarcoma, CNS, head & neck and rare cancers |
Instantly find 20 buyers from Chinese PLA General Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction